European Journal of Heart Failure

Advancing knowledge in the field of heart failure management

The European Journal of Heart Failure (EJHF) is dedicated to the advancement of knowledge in the field of heart failure management.

The journal publishes reviews and editorials to improve the understanding, prevention, investigation and treatment of heart failure. Molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, as well as clinical, social and population sciences all form part of the discipline.

Submit your paper

Access your online journal

ESC Journals top-cited articles

ESC Journals top reviewers

European Journal of Heart Failure Top reviewers 2024

Fast Facts

Editor-in-Chief: Michael Böhm (DE)
Current volume: 27 (year 2025)
Issues per subscription: 12
Impact Factor 2024: 10.8

Editor-in-chief History

Name	Start Date	End Date
Professor John Cleland	01/01/1999	31/12/2004
Professor Karl Swedberg	01/01/2005	31/12/2009
Professor Dirk J. Van Veldhuisen	01/01/2010	31/12/2014
Professor Marco Metra	01/01/2015	31/03/2024
Professor Michael Böhm	01/04/2024

Member Benefits

HFA Members can benefit from discounted or free online access and a print subscription to the European Journal of Heart Failure.

New: Healthcare professionals practicing in low and lower-middle income countries (World Bank classification) are now eligible for a reduced Membership rate.

Become a member

Subscriptions

Subscribe

Connect with us on X

@ESC_Journals

Updates on latest articles

Receive the table of contents in your mailbox.

Track topics and authors important to you and receive articles in your mailbox.

Sign up

For Authors

Before being published, all manuscripts go through double-blind peer review by experienced international experts.

Most recent articles from EJHF

01 Dec 2025

Why healthcare providers' adherence to guideline‐directed medical therapy is only half the battle

Author(s): Martin Schulz, Felix Mahfoud, Ulrich Laufs

28 Nov 2025

Pharmacological treatment for patients with obesity and heart failure: Focus on glucagon‐like peptide‐1 receptor agonists. European Journal of Heart Failure expert consensus document

Author(s): Luca Monzo, Gianluigi Savarese, Wilfried Mullens, Amr Abdin, Biykem Bozkurt, Ovidiu Chioncel, Seif El Hadidi, Thomas M. Gorter, Riccardo M. Inciardi, Mark C. Petrie, Gabriele G. Schiattarella, Davide Stolfo, Marco Metra, Nicolas Girerd

29 Nov 2025

Clinical phenotype and prognosis of real‐world patients with wild‐type transthyretin amyloid cardiomyopathy treated with tafamidis

Author(s): Aldostefano Porcari, Paolo Milani, Simone Longhi, Francesco Cappelli, Fabio Vagnarelli, Alberto Aimo, Alberto Cipriani, Elisa Gardini, Stefania Marazia, Emanuele Monda, Giacomo Tini, Beatrice Musumeci, Matteo Serenelli, Anna Cantone, Carla Lofiego, Marco Marini, Giuseppe Vergaro, Grazia Foti, Francesco Musca, Daniela Tomasoni, Giacomo Bonacchi, Federica Colio, Giulio Sinigiani, Laura De Michieli, Francesca Sturdà, Marco Pozzan, Piero Gentile, Samuela Carigi, Michela Bartolotti, Giuseppe Sena, Irene Ruotolo, Giuseppe Damiano Sanna, Margherita Zanoletti, Marco Canepa, Massimo Di Marco, Emilia D'Elia, Gianluca Di Bella, Mauro Driussi, Massimo Imazio, Federico Perfetto, Elena Biagini, Giuseppe Limongelli, Marco Metra, Michele Emdin, Giampaolo Merlini, Stefano Perlini, Marco Merlo, Giovanni Palladini, Gianfranco Sinagra

26 Nov 2025

Effects of semaglutide in obesity‐related heart failure with preserved ejection fraction across the age spectrum: Findings from the STEP‐HFpEF programme

Author(s): Ambarish Pandey, Michael Moroney, Subodh Verma, Barry A. Borlaug, Javed Butler, Melanie J. Davies, Dalane W. Kitzman, Sanjiv J. Shah, Mark C. Petrie, Cecilia Rönnbäck, Anne Domdey, Søren Rasmussen, Khaja M. Chinnakondepalli, Shachi Patel, Mikhail N. Kosiborod

Show navigation Hide navigation